These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32169580)

  • 1. Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Int J Biochem Cell Biol; 2020 May; 122():105739. PubMed ID: 32169580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
    Bashash D; Delshad M; Riyahi N; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M
    Eur J Pharmacol; 2018 Dec; 841():10-18. PubMed ID: 30316766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.
    Li T; Ma R; Zhang Y; Mo H; Yang X; Hu S; Wang L; Novakovic VA; Chen H; Kou J; Bi Y; Yu B; Fang S; Wang J; Zhou J; Shi J
    Cell Death Dis; 2018 Jan; 9(2):75. PubMed ID: 29362482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment.
    Zamani-Moghaddam N; Mousavi FS; Esmaeili S; Yousefi AM; Safaroghli-Azar A; Bashash D
    Cancer Treat Res Commun; 2021; 26():100284. PubMed ID: 33387871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Ozpolat B; Akar U; Zorrilla-Calancha I; Vivas-Mejia P; Acevedo-Alvarez M; Lopez-Berestein G
    Apoptosis; 2008 Jul; 13(7):915-28. PubMed ID: 18491231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro.
    Liu DM; Zhang XD; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6412-6421. PubMed ID: 30338810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells.
    Esmaeili S; Yousefi AM; Delshad M; Bashash D
    Mol Genet Genomic Med; 2023 Mar; 11(3):e2106. PubMed ID: 36398521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis.
    Sayyadi M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Abolghasemi H; Anoushirvani AA; Bashash D
    Arch Med Res; 2020 Oct; 51(7):636-644. PubMed ID: 32553459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxiredoxin 3 Has Important Roles on Arsenic Trioxide Induced Apoptosis in Human Acute Promyelocytic Leukemia Cell Line via Hyperoxidation of Mitochondrial Specific Reactive Oxygen Species.
    Mun YC; Ahn JY; Yoo ES; Lee KE; Nam EM; Huh J; Woo HA; Rhee SG; Seong CM
    Mol Cells; 2020 Sep; 43(9):813-820. PubMed ID: 32975211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
    Bashash D; Ghaffari SH; Zaker F; Kazerani M; Hezave K; Hassani S; Rostami M; Alimoghaddam K; Ghavamzadeh A
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1115-25. PubMed ID: 23293885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia.
    Zhang T; Ma D; Wei D; Lu T; Yu K; Zhang Z; Wang W; Fang Q; Wang J
    Anticancer Drugs; 2020 Feb; 31(2):158-168. PubMed ID: 31584454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells.
    Kumar S; Tchounwou PB
    Environ Toxicol; 2021 Sep; 36(9):1785-1792. PubMed ID: 34042274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
    Chiu HW; Ho YS; Wang YJ
    J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts.
    Maimaitiyiming Y; Zhu HH; Yang C; Naranmandura H
    Drug Metab Rev; 2020 Aug; 52(3):425-437. PubMed ID: 32677488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO).
    Alipour F; Riyahi N; Safaroghli-Azar A; Sari S; Zandi Z; Bashash D
    Int J Biochem Cell Biol; 2019 Nov; 116():105615. PubMed ID: 31539632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance.
    Mosleh M; Safaroghli-Azar A; Bashash D
    Int J Biochem Cell Biol; 2020 May; 122():105734. PubMed ID: 32119989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells.
    Morino Y; Sugiyama H; Yamane K; Kikuchi M; Yamanaka T; Honda K; Monzen S
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38963046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.